Ben Tre Pharmaceutical JSC (STC:DBT) Accumulated Depreciation: ₫0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
14 GF Score
Price ₫13,100.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC Accumulated Depreciation?

Ben Tre Pharmaceutical JSC STC:DBT 14 Accumulated Depreciation is ₫0.00 Mil as of . 20. GuruFocus rates STC:DBT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ben Tre Pharmaceutical JSC Accumulated Depreciation Related Terms

Ben Tre Pharmaceutical JSC Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ben Tre Pharmaceutical JSC Accumulated Depreciation Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
Accumulated Depreciation

Ben Tre Pharmaceutical JSC Semi-Annual Data
Accumulated Depreciation
STC:DBT
14GF Score
Ben Tre Pharmaceutical JSC STC:DBT
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of ₫0.00 Mil mean?
Ben Tre Pharmaceutical JSC (STC:DBT) has a Accumulated Depreciation of ₫0.00 Mil as of . 20. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ben Tre Pharmaceutical JSC and its competitors.
Is Ben Tre Pharmaceutical JSC's Accumulated Depreciation too high?
Ben Tre Pharmaceutical JSC's current Accumulated Depreciation is ₫0.00 Mil. Overall, Ben Tre Pharmaceutical JSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Ben Tre Pharmaceutical JSC's Accumulated Depreciation compare to ZTS and UTHR?
Ben Tre Pharmaceutical JSC's Accumulated Depreciation of ₫0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Ben Tre Pharmaceutical JSC and its competitors. Ben Tre Pharmaceutical JSC's current Accumulated Depreciation is ₫0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ben Tre Pharmaceutical JSC stock overvalued right now?
Ben Tre Pharmaceutical JSC (STC:DBT) has a current Accumulated Depreciation of ₫0.00 Mil. The current Accumulated Depreciation is ₫0.00 Mil. Ben Tre Pharmaceutical JSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Ben Tre Pharmaceutical JSC (STC:DBT), the current Accumulated Depreciation is ₫0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is based in Vietnam. The company is engaged in trading in pharmaceuticals, functional foods, vaccines, cosmetics, medical equipment, & medical machinery. It is also engaged in the Import and export of testing chemicals & biological products, Manufacturing medicines for human treatment, producing pharmaceuticals, chemicals, and medicinal herbs, and Leasing warehouses and premises.
14GF Score

Get the complete analysis for STC:DBT

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫13,100.00
Price